NYSE · CIK 0000012208
BIO BIO-RAD LABORATORIES, INC.
Insider trading from SEC Form 4. Last filing 33 d ago. Close $366.16 on Oct 9, 2026, +51% from the 52-week low and -6% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
11
with a Form 4 at this company
Price and insider trades, last year
BIOOct 9, 2026 · close 366.16
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at BIO-RAD LABORATORIES, INC., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 47Moderate | James Barry EVP, President, LSG sell | $214k 700 shares | -58% | - | |
| 31Weak | Michael Crowley EVP, GBL Commercial Operations sell | $741k 3,000 shares | -27% | - |
Transactions
The last 100 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 5, 2026 | Roop Kalyan Lakkaraju EVP, Chief Financial Officer | MOption exercise Bio-Rad A Common Stock | +1,370 | $0.00 | $0 | 3,956 | 33 d ago |
| Sep 5, 2026 | Jonathan P. DiVincenzo President & COO | MOption exercise Bio-Rad A Common Stock | +1,712 | $0.00 | $0 | 2,631 | 33 d ago |
| Sep 5, 2026 | Norman D Schwartz Chairman & CEO | MOption exercise Bio-Rad A Common Stock | +4,109 | $0.00 | $0 | 450,294 | 33 d ago |
| Sep 5, 2026 | James Barry EVP, President, LSG | MOption exercise Bio-Rad A Common Stock | +1,027 | $0.00 | $0 | 1,808 | 33 d ago |
| Sep 5, 2026 | Schwartz Allison director | MOption exercise Bio-Rad A Common Stock | +228 | $0.00 | $0 | 1,758 | 33 d ago |
| Sep 5, 2026 | Rajat Mehta EVP, GBL Commercial Operations | MOption exercise Bio-Rad A Common Stock | +456 | $0.00 | $0 | 599 | 33 d ago |
| Sep 5, 2026 | Sedat Evran EVP, Global Supply Chain | MOption exercise Bio-Rad A Common Stock | +1,027 | $0.00 | $0 | 3,345 | 33 d ago |
| Sep 5, 2026 | Courtney C Enloe EVP, General Counsel & Sec | MOption exercise Bio-Rad A Common Stock | +685 | $0.00 | $0 | 1,435 | 33 d ago |
| Sep 5, 2026 | Eva Anette Engelhardt EVP, President, CDG | MOption exercise Bio-Rad A Common Stock | +1,027 | $0.00 | $0 | 1,530 | 33 d ago |
| Sep 5, 2026 | Roop Kalyan Lakkaraju EVP, Chief Financial Officer | FTax withholding Bio-Rad A Common Stock | -559 | $386.11 | $216k | 3,397 | 33 d ago |
| Sep 5, 2026 | James Barry EVP, President, LSG | FTax withholding Bio-Rad A Common Stock | -369 | $386.11 | $142k | 1,439 | 33 d ago |
| Sep 5, 2026 | Eva Anette Engelhardt EVP, President, CDG | FTax withholding Bio-Rad A Common Stock | -369 | $386.11 | $142k | 1,161 | 33 d ago |
| Sep 5, 2026 | Rajat Mehta EVP, GBL Commercial Operations | FTax withholding Bio-Rad A Common Stock | -233 | $386.11 | $90k | 366 | 33 d ago |
| Sep 5, 2026 | Jonathan P. DiVincenzo President & COO | FTax withholding Bio-Rad A Common Stock | -668 | $386.11 | $258k | 1,963 | 33 d ago |
| Sep 5, 2026 | Sedat Evran EVP, Global Supply Chain | FTax withholding Bio-Rad A Common Stock | -329 | $386.11 | $127k | 3,016 | 33 d ago |
| Sep 5, 2026 | Schwartz Allison director | FTax withholding Bio-Rad A Common Stock | -82 | $386.11 | $32k | 1,676 | 33 d ago |
| Sep 5, 2026 | Courtney C Enloe EVP, General Counsel & Sec | FTax withholding Bio-Rad A Common Stock | -246 | $386.11 | $95k | 1,189 | 33 d ago |
| Sep 5, 2026 | Norman D Schwartz Chairman & CEO | FTax withholding Bio-Rad A Common Stock | -2,876 | $386.11 | $1.1M | 447,418 | 33 d ago |
| Sep 6, 2026 | Courtney C Enloe EVP, General Counsel & Sec | MOption exercise Bio-Rad A Common Stock | +768 | $0.00 | $0 | 1,957 | 33 d ago |
| Sep 6, 2026 | Eva Anette Engelhardt EVP, President, CDG | MOption exercise Bio-Rad A Common Stock | +1,152 | $0.00 | $0 | 2,313 | 33 d ago |
| Sep 6, 2026 | James Barry EVP, President, LSG | MOption exercise Bio-Rad A Common Stock | +1,056 | $0.00 | $0 | 2,495 | 33 d ago |
| Sep 5, 2026 | Rajat Mehta EVP, GBL Commercial Operations | MOption exercise Bio-Rad A Common Stock | +1,370 | $0.00 | $0 | 1,736 | 33 d ago |
| Sep 6, 2026 | Roop Kalyan Lakkaraju EVP, Chief Financial Officer | MOption exercise Bio-Rad A Common Stock | +1,536 | $0.00 | $0 | 4,933 | 33 d ago |
| Sep 6, 2026 | Schwartz Allison director | MOption exercise Bio-Rad A Common Stock | +92 | $0.00 | $0 | 1,768 | 33 d ago |
| Sep 6, 2026 | Sedat Evran EVP, Global Supply Chain | MOption exercise Bio-Rad A Common Stock | +864 | $0.00 | $0 | 3,880 | 33 d ago |
| Sep 4, 2026 | Jonathan P. DiVincenzo President & COO | AGrant or award Restricted Stock Unitsderivative | +6,326 | $0.00 | $0 | 6,326 | 33 d ago |
| Sep 6, 2026 | Norman D Schwartz Chairman & CEO | MOption exercise Bio-Rad A Common Stock | +3,455 | $0.00 | $0 | 450,873 | 33 d ago |
| Sep 6, 2026 | Norman D Schwartz Chairman & CEO | FTax withholding Bio-Rad A Common Stock | -1,854 | $386.11 | $716k | 449,019 | 33 d ago |
| Sep 6, 2026 | Courtney C Enloe EVP, General Counsel & Sec | FTax withholding Bio-Rad A Common Stock | -305 | $386.11 | $118k | 1,652 | 33 d ago |
| Sep 5, 2026 | Jonathan P. DiVincenzo President & COO | MOption exercise Restricted Stock Unitsderivative | -1,712 | $0.00 | $0 | 5,138 | 33 d ago |
| Sep 6, 2026 | Eva Anette Engelhardt EVP, President, CDG | FTax withholding Bio-Rad A Common Stock | -485 | $386.11 | $187k | 1,828 | 33 d ago |
| Sep 6, 2026 | Schwartz Allison director | FTax withholding Bio-Rad A Common Stock | -34 | $386.11 | $13k | 1,734 | 33 d ago |
| Sep 6, 2026 | James Barry EVP, President, LSG | FTax withholding Bio-Rad A Common Stock | -470 | $386.11 | $181k | 2,025 | 33 d ago |
| Sep 6, 2026 | Roop Kalyan Lakkaraju EVP, Chief Financial Officer | FTax withholding Bio-Rad A Common Stock | -782 | $386.11 | $302k | 4,151 | 33 d ago |
| Sep 6, 2026 | Sedat Evran EVP, Global Supply Chain | FTax withholding Bio-Rad A Common Stock | -277 | $386.11 | $107k | 3,603 | 33 d ago |
| Sep 5, 2026 | Rajat Mehta EVP, GBL Commercial Operations | FTax withholding Bio-Rad A Common Stock | -504 | $386.11 | $195k | 1,232 | 33 d ago |
| Sep 4, 2026 | Schwartz Allison director | AGrant or award Restricted Stock Unitsderivative | +719 | $0.00 | $0 | 719 | 33 d ago |
| Sep 4, 2026 | James Barry EVP, President, LSG | AGrant or award Restricted Stock Unitsderivative | +4,313 | $0.00 | $0 | 4,313 | 33 d ago |
| Sep 4, 2026 | Roop Kalyan Lakkaraju EVP, Chief Financial Officer | AGrant or award Restricted Stock Unitsderivative | +6,326 | $0.00 | $0 | 6,326 | 33 d ago |
| Sep 4, 2026 | Sedat Evran EVP, Global Supply Chain | AGrant or award Restricted Stock Unitsderivative | +4,026 | $0.00 | $0 | 4,026 | 33 d ago |
| Sep 4, 2026 | Courtney C Enloe EVP, General Counsel & Sec | AGrant or award Restricted Stock Unitsderivative | +2,876 | $0.00 | $0 | 2,876 | 33 d ago |
| Sep 4, 2026 | Eva Anette Engelhardt EVP, President, CDG | AGrant or award Restricted Stock Unitsderivative | +4,313 | $0.00 | $0 | 4,313 | 33 d ago |
| Sep 4, 2026 | Rajat Mehta EVP, GBL Commercial Operations | AGrant or award Restricted Stock Unitsderivative | +4,601 | $0.00 | $0 | 4,601 | 33 d ago |
| Sep 5, 2026 | Roop Kalyan Lakkaraju EVP, Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative | -1,370 | $0.00 | $0 | 4,110 | 33 d ago |
| Sep 5, 2026 | Sedat Evran EVP, Global Supply Chain | MOption exercise Restricted Stock Unitsderivative | -1,027 | $0.00 | $0 | 3,083 | 33 d ago |
| Sep 5, 2026 | Courtney C Enloe EVP, General Counsel & Sec | MOption exercise Restricted Stock Unitsderivative | -685 | $0.00 | $0 | 2,055 | 33 d ago |
| Sep 5, 2026 | Eva Anette Engelhardt EVP, President, CDG | MOption exercise Restricted Stock Unitsderivative | -1,027 | $0.00 | $0 | 3,083 | 33 d ago |
| Sep 5, 2026 | Schwartz Allison director | MOption exercise Restricted Stock Unitsderivative | -228 | $0.00 | $0 | 686 | 33 d ago |
| Sep 5, 2026 | Rajat Mehta EVP, GBL Commercial Operations | MOption exercise Restricted Stock Unitsderivative | -456 | $0.00 | $0 | 1,371 | 33 d ago |
| Sep 5, 2026 | James Barry EVP, President, LSG | MOption exercise Restricted Stock Unitsderivative | -1,027 | $0.00 | $0 | 3,083 | 33 d ago |
| Sep 6, 2026 | Courtney C Enloe EVP, General Counsel & Sec | MOption exercise Restricted Stock Unitsderivative | -768 | $0.00 | $0 | 1,536 | 33 d ago |
| Sep 5, 2026 | Rajat Mehta EVP, GBL Commercial Operations | MOption exercise Restricted Stock Unitsderivative | -1,370 | $0.00 | $0 | 4,110 | 33 d ago |
| Sep 6, 2026 | Roop Kalyan Lakkaraju EVP, Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative | -1,536 | $0.00 | $0 | 3,072 | 33 d ago |
| Sep 6, 2026 | Eva Anette Engelhardt EVP, President, CDG | MOption exercise Restricted Stock Unitsderivative | -1,152 | $0.00 | $0 | 2,304 | 33 d ago |
| Sep 6, 2026 | Schwartz Allison director | MOption exercise Restricted Stock Unitsderivative | -92 | $0.00 | $0 | 185 | 33 d ago |
| Sep 6, 2026 | James Barry EVP, President, LSG | MOption exercise Restricted Stock Unitsderivative | -1,056 | $0.00 | $0 | 2,112 | 33 d ago |
| Sep 6, 2026 | Sedat Evran EVP, Global Supply Chain | MOption exercise Restricted Stock Unitsderivative | -864 | $0.00 | $0 | 1,728 | 33 d ago |
| Sep 4, 2026 | Norman D Schwartz Chairman & CEO | AGrant or award Restricted Stock Unitsderivative | +17,251 | $0.00 | $0 | 17,251 | 33 d ago |
| Sep 5, 2026 | Norman D Schwartz Chairman & CEO | MOption exercise Restricted Stock Unitsderivative | -4,109 | $0.00 | $0 | 12,330 | 33 d ago |
| Sep 6, 2026 | Norman D Schwartz Chairman & CEO | MOption exercise Restricted Stock Unitsderivative | -3,455 | $0.00 | $0 | 6,912 | 33 d ago |
| Sep 1, 2026 | James Barry EVP, President, LSG | MOption exercise Bio-Rad A Common Stock | +425 | $0.00 | $0 | 935 | 39 d ago |
| Sep 1, 2026 | Norman D Schwartz Chairman & CEO | MOption exercise Bio-Rad A Common Stock | +5,087 | $0.00 | $0 | 448,521 | 39 d ago |
| Sep 1, 2026 | Schwartz Allison director | MOption exercise Bio-Rad A Common Stock | +117 | $0.00 | $0 | 1,573 | 39 d ago |
| Sep 1, 2026 | James Barry EVP, President, LSG | FTax withholding Bio-Rad A Common Stock | -154 | $380.96 | $59k | 781 | 39 d ago |
| Sep 1, 2026 | Norman D Schwartz Chairman & CEO | FTax withholding Bio-Rad A Common Stock | -2,336 | $380.96 | $890k | 446,185 | 39 d ago |
| Sep 1, 2026 | Schwartz Allison director | FTax withholding Bio-Rad A Common Stock | -43 | $380.96 | $16k | 1,530 | 39 d ago |
| Sep 1, 2026 | James Barry EVP, President, LSG | MOption exercise Restricted Stock Unitsderivative | -174 | $0.00 | $0 | 0 | 39 d ago |
| Sep 1, 2026 | Schwartz Allison director | MOption exercise Restricted Stock Unitsderivative | -42 | $0.00 | $0 | 0 | 39 d ago |
| Sep 1, 2026 | Schwartz Allison director | MOption exercise Restricted Stock Unitsderivative | -75 | $0.00 | $0 | 75 | 39 d ago |
| Sep 1, 2026 | James Barry EVP, President, LSG | MOption exercise Restricted Stock Unitsderivative | -251 | $0.00 | $0 | 251 | 39 d ago |
| Sep 1, 2026 | Norman D Schwartz Chairman & CEO | MOption exercise Restricted Stock Unitsderivative | -2,082 | $0.00 | $0 | 0 | 39 d ago |
| Sep 1, 2026 | Norman D Schwartz Chairman & CEO | MOption exercise Restricted Stock Unitsderivative | -3,005 | $0.00 | $0 | 3,005 | 39 d ago |
| Nov 6, 2025 | James Barry EVP, President, LSG | SOpen-market sale Bio-Rad A Common Stock | -700 | $306.18 | $214k | 510 | Nov 10, 2025 |
| Oct 24, 2025 | Jonathan P. DiVincenzo President & COO | MOption exercise Bio-Rad A Common Stock | +1,869 | $0.00 | $0 | 1,869 | Oct 28, 2025 |
| Oct 24, 2025 | Jonathan P. DiVincenzo President & COO | FTax withholding Bio-Rad A Common Stock | -950 | $339.75 | $323k | 919 | Oct 28, 2025 |
| Oct 24, 2025 | Jonathan P. DiVincenzo President & COO | MOption exercise Restricted Stock Unitsderivative | -1,869 | $0.00 | $0 | 5,609 | Oct 28, 2025 |
| Oct 20, 2025 | Sedat Evran EVP, Global Supply Chain | MOption exercise Bio-Rad A Common Stock | +1,044 | $0.00 | $0 | 2,568 | Oct 21, 2025 |
| Oct 20, 2025 | Sedat Evran EVP, Global Supply Chain | FTax withholding Bio-Rad A Common Stock | -335 | $321.90 | $108k | 2,233 | Oct 21, 2025 |
| Oct 20, 2025 | Sedat Evran EVP, Global Supply Chain | MOption exercise Restricted Stock Unitsderivative | -1,044 | $0.00 | $0 | 2,088 | Oct 21, 2025 |
| Sep 6, 2025 | Schwartz Allison director | MOption exercise Bio-Rad A Common Stock | +92 | $0.00 | $0 | 1,489 | Sep 9, 2025 |
| Sep 6, 2025 | James Barry EVP, President, LSG | MOption exercise Bio-Rad A Common Stock | +1,056 | $0.00 | $0 | 1,588 | Sep 9, 2025 |
| Sep 6, 2025 | Norman D Schwartz Chairman & CEO | MOption exercise Bio-Rad A Common Stock | +3,455 | $0.00 | $0 | 444,962 | Sep 9, 2025 |
| Sep 6, 2025 | Eva Anette Engelhardt EVP, President, CDG | MOption exercise Bio-Rad A Common Stock | +1,152 | $0.00 | $0 | 1,309 | Sep 9, 2025 |
| Sep 6, 2025 | Roop Kalyan Lakkaraju EVP, Chief Financial Officer | MOption exercise Bio-Rad A Common Stock | +1,535 | $0.00 | $0 | 2,394 | Sep 9, 2025 |
| Sep 6, 2025 | Colleen Corey EVP, Global Human Resources | MOption exercise Bio-Rad A Common Stock | +576 | $0.00 | $0 | 19,759 | Sep 9, 2025 |
| Sep 6, 2025 | Sedat Evran EVP, Global Supply Chain | MOption exercise Bio-Rad A Common Stock | +864 | $0.00 | $0 | 1,801 | Sep 9, 2025 |
| Sep 6, 2025 | Courtney C Enloe EVP, General Counsel & Sec | MOption exercise Bio-Rad A Common Stock | +768 | $0.00 | $0 | 904 | Sep 9, 2025 |
| Sep 5, 2025 | Rajat Mehta EVP, GBL Commercial Operations | AGrant or award Restricted Stock Unitsderivative | +1,827 | $0.00 | $0 | 1,827 | Sep 9, 2025 |
| Sep 5, 2025 | Jonathan P. DiVincenzo President & COO | AGrant or award Restricted Stock Unitsderivative | +6,850 | $0.00 | $0 | 6,850 | Sep 9, 2025 |
| Sep 6, 2025 | Schwartz Allison director | FTax withholding Bio-Rad A Common Stock | -33 | $295.43 | $9,749 | 1,456 | Sep 9, 2025 |
| Sep 6, 2025 | James Barry EVP, President, LSG | FTax withholding Bio-Rad A Common Stock | -378 | $295.43 | $112k | 1,210 | Sep 9, 2025 |
| Sep 6, 2025 | Norman D Schwartz Chairman & CEO | FTax withholding Bio-Rad A Common Stock | -1,528 | $295.43 | $451k | 443,434 | Sep 9, 2025 |
| Sep 6, 2025 | Eva Anette Engelhardt EVP, President, CDG | FTax withholding Bio-Rad A Common Stock | -413 | $295.43 | $122k | 896 | Sep 9, 2025 |
| Sep 6, 2025 | Roop Kalyan Lakkaraju EVP, Chief Financial Officer | FTax withholding Bio-Rad A Common Stock | -550 | $295.43 | $162k | 1,844 | Sep 9, 2025 |
| Sep 6, 2025 | Colleen Corey EVP, Global Human Resources | FTax withholding Bio-Rad A Common Stock | -209 | $295.43 | $62k | 19,550 | Sep 9, 2025 |
| Sep 5, 2025 | Rajat Mehta EVP, GBL Commercial Operations | AGrant or award Restricted Stock Unitsderivative | +5,480 | $0.00 | $0 | 5,480 | Sep 9, 2025 |
| Sep 6, 2025 | Sedat Evran EVP, Global Supply Chain | FTax withholding Bio-Rad A Common Stock | -277 | $295.43 | $82k | 1,524 | Sep 9, 2025 |
| Sep 6, 2025 | Courtney C Enloe EVP, General Counsel & Sec | FTax withholding Bio-Rad A Common Stock | -275 | $295.43 | $81k | 629 | Sep 9, 2025 |
| Sep 5, 2025 | Colleen Corey EVP, Global Human Resources | AGrant or award Restricted Stock Unitsderivative | +2,740 | $0.00 | $0 | 2,740 | Sep 9, 2025 |
| Sep 5, 2025 | Roop Kalyan Lakkaraju EVP, Chief Financial Officer | AGrant or award Restricted Stock Unitsderivative | +5,480 | $0.00 | $0 | 5,480 | Sep 9, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Schwartz Allisondirector
- James BarryEVP, President, LSG
- Colleen CoreyEVP, Global Human Resources
- Michael CrowleyEVP, GBL Commercial Operations
- Jonathan P. DiVincenzoPresident & COO
- Eva Anette EngelhardtEVP, President, CDG
- Courtney C EnloeEVP, General Counsel & Sec
- Sedat EvranEVP, Global Supply Chain
- Roop Kalyan LakkarajuEVP, Chief Financial Officer
- Rajat MehtaEVP, GBL Commercial Operations
- Norman D SchwartzChairman & CEO
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.